Acceleration of carboxylesterase-mediated activation of irinotecan to SN-38 by serum from patients with end-stage kidney disease.
Cancer Chemother Pharmacol
; 81(6): 1121-1128, 2018 06.
Article
in En
| MEDLINE
| ID: mdl-29693202
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Microsomes, Liver
/
Carboxylesterase
/
Topoisomerase I Inhibitors
/
Irinotecan
/
Kidney Failure, Chronic
Type of study:
Observational_studies
Limits:
Humans
Language:
En
Journal:
Cancer Chemother Pharmacol
Year:
2018
Document type:
Article
Affiliation country:
Japan